India Pesticides Limited (IPL) is a research and development-driven chemical manufacturer specializing in agrochemical technicals and Active Pharmaceutical Ingredients (APIs), complemented by a growing formulations business. The company has established itself as a significant player in the global market, being the sole Indian manufacturer and a leading global producer of certain Thiocarbamate, Fungicide, and Herbicide Technicals. IPL's operations are supported by two advanced, in-house laboratories recognized by the Department of Scientific and Industrial Research (DSIR), which drive its capability to develop innovative and client-specific molecules efficiently. The company's manufacturing infrastructure includes facilities in the Lucknow and Hardoi districts of Uttar Pradesh, with an upcoming plant planned for Hamirpur, U.P. As of December 2025, IPL possesses an installed capacity of 28,200 metric tons per annum (MTPA) for technicals and 10,000 MTPA for formulations. With a global footprint extending to over 35 countries and a focus on backward integration to reduce import dependency, IPL has built long-standing relationships with major multinational corporations, positioning itself as a key partner in the global agrochemical supply chain.

Official Website: http://www.indiapesticideslimited.com/

• Q3 FY2026 Performance:

• Total Income: Grew by 30.7% year-over-year (YoY) to ₹229 crore from ₹175 crore in Q3 FY25, driven by strong volume growth of approximately 32%.

• EBITDA: Increased by 39.7% YoY to ₹41 crore, with the EBITDA margin improving to 17.9% from 16.7% in the prior year's quarter.

• Profit After Tax (PAT): Rose by 41.2% YoY to ₹23 crore. The PAT margin expanded to 9.9% compared to 9.2% in Q3 FY25.

• Earnings Per Share (EPS): Stood at ₹1.97, a 40.7% increase from ₹1.40 in Q3 FY25.

• 9M FY2026 Performance:

• Total Income: Grew by 27.6% YoY to ₹808 crore for the nine months ended December 31, 2025.

• EBITDA: Showed significant growth of 47.7% YoY, reaching ₹149 crore. The EBITDA margin improved substantially to 18.4% from 15.9%.

• Profit After Tax (PAT): Increased by 43.9% YoY to ₹89 crore, with the PAT margin expanding to 11.0% from 9.8%.

• Earnings Per Share (EPS): Grew by 44.1% YoY to ₹7.75 for the nine-month period.

• Revenue Mix (Q3 FY2026):

• By Product: Technicals and APIs contributed 73% of total revenue, while Formulations accounted for the remaining 27%.

• By Geography: Domestic sales represented 58% of revenue, with Exports making up the other 42%.

The company demonstrated robust financial performance with significant YoY growth in revenue, EBITDA, and PAT, supported by strong volume growth and margin expansion across its business segments.

• Market Leadership in Niche Products: IPL is the sole Indian manufacturer and a leading global manufacturer of Thiocarbamate, Fungicide, and Herbicide Technicals, giving it a strong competitive advantage in these specific product categories.

• Strong In-House R&D Capabilities: The company operates two advanced DSIR-registered R&D centers, enabling it to develop new products, optimize processes for cost reduction, and achieve critical certifications like the Technical Equivalence (TEQ) from the European Union.

• Backward Integration: IPL has successfully commissioned an intermediate plant for one of its key fungicides, which was previously imported. This strategic move enhances supply chain independence, reduces reliance on external sources, and supports margin expansion.

• Diversified and High-Quality Customer Base: The company has long-term relationships with over 60 international customers, including major multinational corporations. Revenue concentration from its top 10 customers has been steadily decreasing, falling from 61.0% in FY23 to 45.0% in 9M FY26, indicating a successful client diversification strategy.

IPL's competitive edge is built on its market leadership in specialized products, strong R&D, strategic backward integration, and a well-diversified global customer base.

• Capitalizing on Global Supply Chain Shifts: The company is strategically employing a ‘China plus one’ strategy. This positions IPL to capture market share from global customers seeking to de-risk their supply chains and reduce their dependence on China.

• Strong Demand Environment: The management commentary indicates consistent demand across key export markets, particularly in the European Union and Australia. Domestically, there is a gradual recovery and increased demand for herbicides and their intermediates.

The company is well-positioned to capitalize on the global 'China plus one' trend, supported by a favorable demand environment in both export and domestic markets.

• Volume-Led Revenue Growth: The company's 31% YoY revenue growth in Q3 FY26 was primarily driven by an overall volume growth of approximately 32%, demonstrating strong underlying demand for its products despite some price softening in certain molecules.

• Strong Export Performance: Export sales grew to ₹96 crore from ₹75 crore in Q3 FY25, led by strong performance in the European Union and Australia. Exports now constitute 42% of the company's revenue.

• Robust Domestic Growth: Domestic sales saw a significant rise to ₹129 crore from ₹97 crore, fueled by increased demand for herbicides and their intermediates.

• New Product Registrations: In Q3 FY26, the company obtained 5 new registrations from the Central Insecticides Board (CIB) and 6 new overseas registrations in Europe, Australia, and New Zealand, expanding its addressable market and product pipeline.

Growth is being driven by strong execution, with robust volume increases in both domestic and export markets, further supported by a continuous expansion of its product registrations globally.

• Make in India Initiative: The company's focus on backward integration and indigenous sourcing of raw materials aligns with the 'Make in India' initiative, creating opportunities for cost reduction and enhanced supply chain security.

• Global De-risking (China Plus One): As global corporations continue to diversify their supply chains away from China, IPL's established manufacturing capabilities and R&D strength present a significant opportunity to secure new long-term contracts and partnerships.

IPL is strategically positioned to leverage macro trends such as the 'Make in India' initiative and global supply chain diversification to fuel its future growth.

• Current Installed Capacity: As of December 31, 2025, the company's total installed capacity stands at 28,200 MTPA for Technicals and 10,000 MTPA for Formulations, spread across its facilities in Dewa Road (Lucknow) and Sandila (Hardoi).

• Planned Capital Expenditure: The company has a budgeted capital expenditure of approximately ₹116 Crore for FY26.

• Expansion Projects:

• Sandila Plant: Initiatives are underway to realign the existing plant for better capacity utilization and to expand the installed capacity of the intermediate plant.

• Hamirpur Plant: The upcoming greenfield project at Hamirpur is identified as a significant driver for the company's future growth trajectory.

The company is actively investing in capacity expansion and operational efficiency through a clearly defined capex plan to meet growing future demand.

• Portfolio Expansion: A core strategy is to continuously expand the overall product range by increasing the number of Technicals manufactured, leveraging its R&D capabilities.

• Deepen Backward Integration: The company plans to further reduce its dependency on imported raw materials through indigenous sourcing and in-house R&D for process technology.

• Cost and Process Optimization: R&D efforts are focused on optimizing existing manufacturing processes to achieve overall cost reductions and improve efficiency.

• Market Penetration: The company aims to amplify its distribution network and continue registering its products in regulated markets to expand its global reach and customer base.

Future strategy is centered on expanding the product portfolio, enhancing self-sufficiency through backward integration, and optimizing costs to drive sustainable growth.

• Q3 FY26 Margin Performance:

• Gross Margin: Stood at 49.6%, a slight moderation from 52.7% in Q3 FY25, attributed to price softening in certain molecules.

• EBITDA Margin: Improved to 17.9% from 16.7% YoY, reflecting strong operating leverage from higher volumes.

• PAT Margin: Expanded to 9.9% from 9.2% YoY.

• 9M FY26 Margin Performance:

• Gross Margin: Improved to 46.1% from 45.0% in 9M FY25.

• EBITDA Margin: Showed a significant expansion to 18.4% from 15.9% YoY.

• PAT Margin: Expanded to 11.0% from 9.8% YoY.

The company has successfully expanded its operating and net profit margins through higher volumes and operational efficiency, despite some pressure on gross margins in the recent quarter.

• Customer Concentration: Revenue from the top 10 customers constituted 45.0% of the total in 9M FY26. While this represents a concentration risk, the company has actively mitigated it by reducing this figure from 55.0% in FY22 and 61.0% in FY23, indicating successful customer base diversification.

While a notable portion of revenue comes from key customers, this risk is being effectively managed and reduced through a deliberate strategy of client diversification.

• Renewable Energy Initiative: The company began receiving 6 MW of solar power at its Sandila Unit from a Group Captive Solar Plant, effective October 1, 2025. This significantly enhances its renewable energy portfolio and reduces reliance on conventional power.

• Corporate Social Responsibility (CSR): The company is actively engaged in CSR through flagship initiatives like "Samagra Sudhar" (adopting and developing four villages near its Sandila facility) and "Chuppi Tod; Halla Bol" (spreading awareness on the POCSO Act).

• Awards and Recognition: IPL received the CSR Impact Award for its key initiatives and the Social Responsibility Excellence Award at the 6th PMFAI Annual AGCHEM Award Ceremony, underscoring its commitment to community welfare.

• ESG Disclosures: The company maintains a detailed ESG disclosure profile, reporting key metrics such as recycling 842.03 MT of waste, consuming 6,70,059.7 GJ of renewable energy, and having 33.33% independent directors on its board for FY2025.

The company is making tangible progress on its ESG goals, particularly in renewable energy adoption, and has received external recognition for its impactful CSR programs.